Gotham Asset Management’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,886
Closed -$136K 1766
2025
Q2
$136K Buy
14,886
+516
+4% +$666 ﹤0.01% 1604
2025
Q1
$140K Buy
14,370
+3,927
+38% +$4.71K ﹤0.01% 1490
2024
Q4
$105K Buy
+10,443
New +$9.21K ﹤0.01% 1403

Other funds holding LUCD

Gotham Asset Management's LUCD Position: Q3 2025 in Review

Gotham Asset Management sold out of Lucid Diagnostics (LUCD) in Q3 2025, closing a stake of 14,886 shares — an estimated $136K sold.

Gotham Asset Management first reported a position in LUCD in Q4 2024 and held it in 3 quarters. The position peaked at $140K in Q1 2025. 86 funds tracked by Wall St. Rank hold LUCD as of Q3 2025.

  • Gotham Asset Management reported no remaining Lucid Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Gotham Asset Management sold 14,886 Lucid Diagnostics shares in Q3 2025, an estimated $136K.
  • Gotham Asset Management first reported a position in Lucid Diagnostics in Q4 2024 and held it in 3 quarters.
  • Gotham Asset Management's Lucid Diagnostics position peaked at $140K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2025.

Based on Gotham Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.